Securities Code: 300204 Securities Abbreviation: Shuntai Shen Announcement Number: 2026-036 Shuntai Shen (Beijing) Biopharmaceutical Co., Ltd. Notice of the 2026 First Extraordinary General Meeting of Shareholders The Company and all members of the Board of Directors guarantee that the content of the information disclosure is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions. Important Notice: Shuntai Shen (Beijing) Biopharmaceutical Co., Ltd. (hereinafter referred to as the "Company") decided at the 13th meeting of the Sixth Board of Directors to hold the 2026 First Extraordinary General Meeting of Shareholders (hereinafter referred to as the "Shareholders' Meeting") on July 8, 2026 (Wednesday). The relevant matters of this Shareholders' Meeting are hereby notified as follows: I. Basic Information of the Meeting
- Session of the Shareholders' Meeting: 2026 First Extraordinary General Meeting of Shareholders
- Convener of the Shareholders' Meeting: The Board of Directors
- The convening and holding of this meeting comply with the "Company Law of the People's Republic of China," the "Shenzhen Stock Exchange GEM Stock Listing Rules," the "Shenzhen Stock Exchange Listed Company Self-Regulatory Supervision Guidelines No. 2—Standardized Operation of GEM Listed Companies," and other laws, administrative regulations, departmental rules, normative documents, and the "Articles of Association."
- Meeting Time: (1) On-site Meeting Time: July 8, 2026, 14:30 (2) Online Voting Time: The specific time for online voting through the Shenzhen Stock Exchange system is July 8, 2026, 9:15-9:25, 9:30-11:30, 13:00-15:00; the specific time for voting through the Shenzhen Stock Exchange Internet Voting System is any time from July 8, 2026, 9:15 to 15:00.
- Method of Holding the Meeting: Combination of on-site voting and online voting.
- Equity Registration Date: June 30, 2026
- Attendees: (1) Shareholders of common stock registered with Shenzhen Branch of China Securities Depository and Clearing Corporation Limited as of the close of trading on June 30, 2026 (Tuesday). All shareholders of the Company are entitled to attend this Shareholders' Meeting and may entrust an agent in writing to attend the meeting and vote. The agent does not need to be a shareholder of the Company. (See Attachment 2 for the format of the Power of Attorney); (2) Directors and senior management of the Company; (3) Lawyers and other relevant personnel hired by the Company.
- Meeting Location: Conference Room of the Company, No. 36, Jinghai 2nd Road, Beijing Economic-Technological Development Area II. Matters to be Discussed at the Meeting
- List of Proposals for This Shareholders' Meeting | Proposal Code | Proposal Name | Proposal Type | Can Vote in This Column | |---|---|---|---| | 100 | General Proposal: All proposals other than cumulative voting proposals | Non-cumulative Voting Proposal | √ | | 1.00 | Proposal on the Election of Independent Directors and Adjustment of the Board of Directors' Special Committees | Non-cumulative Voting Proposal | √ |
- The above proposals have been reviewed and approved by the 13th meeting of the Sixth Board of Directors held by the Company on June 22, 2026. For details, please refer to the relevant announcement published on the GEM information disclosure website designated by the China Securities Regulatory Commission on June 22, 2026.
- Each proposal will